Testing effectiveness (Phase 2)Study completedNCT01608217What this trial is testingDelta-THC in DementiaWho this might be right forBehavioural DisturbancesPainDementia+2 more Radboud University Medical Center 50
Not applicableUnknownNCT04213391What this trial is testingEffects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's DiseaseWho this might be right forAlzheimer Disease Second Affiliated Hospital, Zhejiang University, School of Medicine 160
Not applicableStudy completedNCT01954550What this trial is testingEffects of Aerobic Exercise for Treating Alzheimer's DiseaseWho this might be right forAlzheimer's Disease, Late Onset University of Minnesota 96
Testing effectiveness (Phase 2)Study completedNCT00224497What this trial is testingA Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 380
Large-scale testing (Phase 3)Ended earlyNCT02327182What this trial is testingSafety Study of MT-4666 in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Tanabe Pharma Corporation 117
Testing effectiveness (Phase 2)UnknownNCT05538507What this trial is testingEfficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseMild Cognitive Impairment Peking Union Medical College Hospital 180
Testing effectiveness (Phase 2)Study completedNCT04018092What this trial is testingThe Revitalize Study in Older Adults at Risk for Alzheimer's DiseaseWho this might be right forCognitive AgingAlzheimer Disease, Protection Against University of Florida 168
Large-scale testing (Phase 3)Study completedNCT03790709What this trial is testingANAVEX2-73 for Treatment of Early Alzheimer's DiseaseWho this might be right forAlzheimer Disease Anavex Life Sciences Corp. 509
Large-scale testing (Phase 3)Ended earlyNCT01900665What this trial is testingProgress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboWho this might be right forAlzheimer's Disease Eli Lilly and Company 2,129
Not applicableEnrolling By InvitationNCT05826379What this trial is testingDaily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in MidlifeWho this might be right forPhysical InactivityWalkingCognitive Health+2 more Milton S. Hershey Medical Center 200
Not applicableUnknownNCT05378659What this trial is testingNeuroinflammation and Alzheimer's Pathology in POCDWho this might be right forPost-Operative ConfusionNeuroinflammatory ResponseAlzheimer Disease University of Tennessee Graduate School of Medicine 120
Not applicableStudy completedNCT01190800What this trial is testingCapacity Assessment in Persons With Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseCapacity to Consent to TreatmentCapacity to Vote+1 more Assistance Publique - Hôpitaux de Paris 400
Testing effectiveness (Phase 2)Study completedNCT00359944What this trial is testingSafety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Sumitomo Pharma America, Inc. 171
Not applicableStudy completedNCT01225809What this trial is testingAD01 Follow up Extension VisitWho this might be right forAlzheimer´s Disease Affiris AG 17
Not applicableStudy completedNCT03016702What this trial is testingThe Cognitive Resilience StudyWho this might be right forAlzheimer Disease Duke University 29
Not applicableEnded earlyNCT03256539What this trial is testingNapping, Sleep, Cognitive Decline and Risk of Alzheimer's DiseaseWho this might be right forSleepAlzheimer DiseaseCognitive Impairment+2 more University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT03560245What this trial is testingBryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On MemantineWho this might be right forAlzheimer Disease Neurotrope Bioscience, Inc. 108
Large-scale testing (Phase 3)Study completedNCT00898807What this trial is testingCitalopram for Agitation in Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseAgitation JHSPH Center for Clinical Trials 186
Large-scale testing (Phase 3)Active Not RecruitingNCT04437511What this trial is testingDonanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)Who this might be right forAlzheimer Disease Eli Lilly and Company 1,736
Early research (Phase 1)Study completedNCT02859207What this trial is testingEvaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy SubjectsWho this might be right forEarly Alzheimer's Disease Eisai Inc. 32